Sugi Predict

Sugi Predict / Targets / EMD

EMD

Emerin · P50402 · EMD on Sugi Atlas →

0 patent compounds predicted against EMD, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to EMD by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Bromocriptine in Dilated Cardiomyopathy Among Women of Reproductive Age PHASE3RECRUITING
Deflazacort in Dysferlinopathies PHASE2/PHASE3COMPLETED
Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for Progeria PHASE2COMPLETED
Observatoire Des Patients Atteints de Laminopathies et Emerinopathies (Observatory for PAtients With Laminopathies and Emerinopathies) nanRECRUITING
DCM Precision Medicine Study nanACTIVE_NOT_RECRUITING
Precision Diagnosis and Therapy for Rare Diseases by Interpreting Non-coding Genomes nanRECRUITING
Cardiac Arrhythmias and Sudden Death in Patients Affected With Laminopathies nanUNKNOWN
Clinical Outcome Study for Dysferlinopathy nanUNKNOWN
Evaluation of Phenotypic and Genetic Properties in Male Subjects Affected By Hypohidrotic Ectodermal Dysplasia (ECP-012) nanCOMPLETED
Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy (LGMD) nanCOMPLETED
Clinical and Genetic Examinations of Dilated Cardiomyopathy nanCOMPLETED
Muscle Tissue Bank for Muscular Dystrophy nanCOMPLETED
Registry and Natural History Study for Progressive Myoclonus Epilepsy Type 1 (EPM1) nanRECRUITING
Prospective Validation of Prostate Biomarkers for Repeat Biopsy nanUNKNOWN
B3 for NMD: Bench to Bedside and Back nanENROLLING_BY_INVITATION
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others nanRECRUITING
Dilated Cardiomyopathy-Cardiac Magnetic Resonance (DCM-CMR) Ancillary Study nanACTIVE_NOT_RECRUITING
Molecular and Genetic Studies of Congenital Myopathies nanRECRUITING
Molecular Analysis of Patients With Neuromuscular Disease nanRECRUITING
MYO-SHARE: MYO-MRI in Neuromuscular Diseases nanENROLLING_BY_INVITATION
Impact of Elastin Mediated Vascular Stiffness on End Organs nanCOMPLETED
Idiopathic Dilated Cardiomyopathy nanCOMPLETED
A Multicenter Phenotype-Genotype Analysis of LGMD Patients in China nanENROLLING_BY_INVITATION
Prospective Becker-Heart-Study nanUNKNOWN
CoMPaSS-NMD - Computational Models for New Patients Stratification Strategies of HNMD nanENROLLING_BY_INVITATION
DMD Gene Variants and Cardiac Dysfunction in Young Males With Dystrophinopathies nanRECRUITING
Heart Rate Variability in Duchenne Muscular Dystrophy During Computer Task nanCOMPLETED
Transcriptomic Analysis to Put an End to Misdiagnosis in Patients With Rare Muscle Diseases nanRECRUITING
Genetics of Ehlers-Danlos Syndrome nanCOMPLETED
Defining the Risk of Ventricular Tachycardia in Genetic Cardiomyopathies nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a EMD binder may also engage these)

ProteinNameSimilarity
O08579 — 1.000 O08579 →
Q63190 — 0.999 Q63190 →
Q91XT4 — 0.989 Q91XT4 →
Q148W8 — 0.988 Q148W8 →
Q2THW0 — 0.988 Q2THW0 →
Q9Y2H5 — 0.988 Q9Y2H5 →
P97868 — 0.987 P97868 →
Q8VDZ4 — 0.987 Q8VDZ4 →
Q5R838 — 0.987 Q5R838 →
B1AZP2 — 0.987 B1AZP2 →
Q9P1A6 — 0.986 Q9P1A6 →
Q75N33 — 0.986 Q75N33 →
Q9H1K0 — 0.986 Q9H1K0 →
Q71H61 — 0.986 Q71H61 →
B5TVM2 — 0.986 B5TVM2 →
A2RUV4 — 0.986 A2RUV4 →
Q8BG95 — 0.986 Q8BG95 →
Q2THX1 — 0.986 Q2THX1 →
O95886 — 0.986 O95886 →
Q640U0 — 0.986 Q640U0 →
A0A1L8ER70 — 0.986 A0A1L8ER70 →
Q2THW7 — 0.986 Q2THW7 →
Q9C0B5 — 0.986 Q9C0B5 →
Q86X29 — 0.986 Q86X29 →
P27715 — 0.986 P27715 →
Q27IV2 — 0.986 Q27IV2 →
O14490 — 0.986 O14490 →
SETD1A Histone-lysine N-methyltransferase SETD1A 0.986 landscape →
Q6PFD5 — 0.986 Q6PFD5 →
Q70IV5 — 0.985 Q70IV5 →